{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:50:10Z","timestamp":1793134210598,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP16lm0103004"],"award-info":[{"award-number":["JP16lm0103004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005946","name":"Hokkaido University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018790","name":"National Institutes for Quantum and Radiological Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.radonc.2024.110385","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T19:09:11Z","timestamp":1718737751000},"page":"110385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Proton and carbon ion radiotherapy for operable early-stage lung cancer; a prospective nationwide registry"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-3027","authenticated-orcid":false,"given":"Hideyuki","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Suefuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-8892","authenticated-orcid":false,"given":"Masaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-7665","authenticated-orcid":false,"given":"Sunao","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9809-9800","authenticated-orcid":false,"given":"Hiromitsu","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Tatebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0626-8142","authenticated-orcid":false,"given":"Nobuteru","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-1688","authenticated-orcid":false,"given":"Takahiro","family":"Waki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisaku","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5276-3665","authenticated-orcid":false,"given":"Takayuki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-5420","authenticated-orcid":false,"given":"Masayuki","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyako","family":"Satouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Shioyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110385_b0005","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2188\/jea.JE20200416","article-title":"Updated trends in cancer in Japan: incidence in 1985\u20132015 and mortality in 1958\u20132018-A sign of decrease in cancer incidence","volume":"31","author":"Katanoda","year":"2021","journal-title":"J Epidemiol"},{"issue":"3","key":"10.1016\/j.radonc.2024.110385_b0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-U","article-title":"Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group","volume":"60","author":"Ginsberg","year":"1995","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.radonc.2024.110385_b0015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jtcvs.2006.02.063","article-title":"Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study","volume":"132","author":"Okada","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"10.1016\/j.radonc.2024.110385_b0020","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","article-title":"Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study","volume":"101","author":"Onishi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110385_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109640","article-title":"Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: a Japanese national registry study (J-CROS-LUNG)","volume":"183","author":"Kubo","year":"2023","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2024.110385_b0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13014-021-01855-w","article-title":"Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer","volume":"16","author":"Bayasgalan","year":"2021","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2024.110385_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-20-00013.1","article-title":"Image-guided hypofractionated proton therapy in early-stage non-small cell lung cancer: a phase 2 study","volume":"7","author":"Kharod","year":"2020","journal-title":"Int J Part Ther"},{"issue":"5","key":"10.1016\/j.radonc.2024.110385_b0040","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ijrobp.2015.07.2278","article-title":"Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403","volume":"93","author":"Nagata","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.radonc.2024.110385_b0045","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","article-title":"Long-term results of stereotactic body radiation therapy in medically inoperable stage I non-small cell lung cancer","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2024.110385_b0050","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.cllc.2013.11.002","article-title":"Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non-small-cell lung cancer","volume":"15","author":"Kanemoto","year":"2014","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.radonc.2024.110385_b0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/cancers13010112","article-title":"Long-term results of single-fraction carbon-ion radiotherapy for non-small cell lung cancer","volume":"13","author":"Ono","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.radonc.2024.110385_b0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijrobp.2019.09.013","article-title":"Proton beam therapy for histologically or clinically diagnosed stage I non-small cell lung cancer (NSCLC): The first nationwide retrospective study in Japan","volume":"106","author":"Ohnishi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110385_b0065","article-title":"Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG)","author":"Kubo","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110385_b0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMoa2212083","article-title":"Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer","volume":"388","author":"Altorki","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.radonc.2024.110385_b0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jtho.2018.10.002","volume":"14","author":"Okami","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"11","key":"10.1016\/j.radonc.2024.110385_b0080","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.21873\/anticanres.15379","article-title":"Hypofractionated proton beam therapy for cT1-2N0M0 non-small cell lung cancer patients with interstitial lung disease","volume":"41","author":"Saito","year":"2021","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.radonc.2024.110385_b0085","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.21873\/anticanres.15778","article-title":"Proton beam therapy in elderly patients with cT1-3N0M0 non-small cell lung cancer","volume":"42","author":"Nakamura","year":"2022","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.radonc.2024.110385_b0090","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s00259-019-04585-0","article-title":"Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy","volume":"47","author":"Shrestha","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.radonc.2024.110385_b0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13014-018-1144-5","article-title":"Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer","volume":"13","author":"Nakajima","year":"2018","journal-title":"Radiat Oncol"},{"issue":"15","key":"10.1016\/j.radonc.2024.110385_b0100","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1002\/cam4.2561","article-title":"Hypofractionated carbon-ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study","volume":"8","author":"Saitoh","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2024.110385_b0105","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/jrr\/rrad008","article-title":"Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG)","volume":"64(Supplement_1)","author":"Okano","year":"2023","journal-title":"J Radiat Res"},{"issue":"10335","key":"10.1016\/j.radonc.2024.110385_b0110","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"West Japan Oncology Group and Japan Clinical Oncology Group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.radonc.2024.110385_b0115","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"STARS Lung Cancer Trials Group. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2024.110385_b0120","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.21037\/jtd.2018.03.64","article-title":"Appropriate lymphadenectomy significantly reduced recurrence after segmentectomy for patients with non-small cell lung cancer","volume":"10","author":"Huang","year":"2018","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.radonc.2024.110385_b0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jjco\/hyaa199","article-title":"Appropriate extent of lymphadenectomy in segmentectomy: a multicenter study","volume":"51","author":"Handa","year":"2021","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2024.110385_b0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5761\/atcs.oa.16-00309","article-title":"Clinicopathological characteristics of lung adenocarcinoma with unexpected lymph node metastasis","volume":"23","author":"Haruki","year":"2017","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"12","key":"10.1016\/j.radonc.2024.110385_b0135","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1007\/s00268-016-3652-5","article-title":"Risk factors for predicting occult lymph node metastasis in patients with clinical stage I non-small cell lung cancer staged by integrated fluorodeoxyglucose positron emission tomography\/computed tomography","volume":"40","author":"Kaseda","year":"2016","journal-title":"World J Surg"},{"issue":"10308","key":"10.1016\/j.radonc.2024.110385_b0140","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"IMpower010 Investigators. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.radonc.2024.110385_b0145","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O\u2019Brien","year":"2022","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.radonc.2024.110385_b0150","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1056\/NEJMoa1716078","article-title":"Neoadjuvant PD-1 blockade in resectable lung cancer","volume":"378","author":"Forde","year":"2018","journal-title":"N Engl J Med."},{"issue":"21","key":"10.1016\/j.radonc.2024.110385_b0155","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"CheckMate 816 Investigators. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.radonc.2024.110385_b0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semradonc.2023.03.012","article-title":"Radiotherapy dose in patients receiving immunotherapy","volume":"33","author":"Fitzgerald","year":"2023","journal-title":"Semin Radiat Oncol"},{"issue":"10405","key":"10.1016\/j.radonc.2024.110385_b0165","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110385_b0170","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.13-2924","article-title":"When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: a decision analysis","volume":"146","author":"Louie","year":"2014","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.radonc.2024.110385_b0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1753465813512545","article-title":"Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation","volume":"8","author":"Haidar","year":"2014","journal-title":"Ther Adv Respir Dis"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024006558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024006558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:37:42Z","timestamp":1762256262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024006558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":35,"alternative-id":["S0167814024006558"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110385","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton and carbon ion radiotherapy for operable early-stage lung cancer; a prospective nationwide registry","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110385"}}